How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Close this folder9 REVIEW AND UPDATE
View the documentPlanning for review
View the documentHow frequently does the national formulary need to be reviewed?
Close this folderReview process
View the documentIdentification of areas in need of change
View the documentDrafting of updated texts for areas where change is necessary
View the documentUpdating texts based on the WHO model formulary
View the documentUpdating texts containing locally added information
View the documentApproval by the national formulary committee and expert advisers
View the documentREFERENCES
 

Updating texts based on the WHO model formulary

Revised editions of the WMF include a list of all changes to the WMLEM at the front to alert users to these changes. This list of changes should be checked first to assess whether changes will also be required in the NF. The latest edition of a NF should always be carefully compared to the latest edition of the WMF, particularly the text of the general therapeutics sections. This is best done by the members of the editorial team who will follow through the whole review process of a particular section or chapter.

The acceptance of new changes made to the WMF in the NF should involve careful appraisal of new information in the context of local guidelines and practices. Detailed discussion by the NFC and expert advisers is always necessary before making significant changes to recommendations about the management of diseases. If a different text style was used for texts copied from the WMF this can greatly facilitate the process of comparing new text from the WMF with that of the NF.

Existing word-processing software packages may also have the capacity to compare different versions of the same document, i.e. the revised file of the WMF may be compared to the same file from the previous edition, thus quickly pinpointing places where changes were effected. Although such electronic editing tools can speed up the comparison process, it will still be necessary to carefully read, compare and comprehend relevant texts before deciding on the appropriate actions.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014